WOLVERINE ASSET MANAGEMENT LLC

Holdings History for SALIX PHARMACEUTICALS INC - NOTE 1.500% 3/1

Investment type: Debt / NOTE 1.500% 3/1

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Principal	Price	All Holders
31 Mar 2015	1.8%	0%	$83,048,000	31,256,000	265.7%	Q1 2015
31 Dec 2014	1.2%	0%	$56,979,000	31,156,000	182.88%	Q4 2014
30 Sep 2014	1.7%	0%	$75,372,000	31,156,000	241.92%	Q3 2014
30 Jun 2014	0.51%	0%	$21,391,000	10,890,000	196.43%	Q2 2014
31 Mar 2014	0.42%	0%	$18,357,000	10,890,000	168.57%	Q1 2014
31 Dec 2013	0.08%	0%	$3,733,000	2,500,000	149.32%	Q4 2013

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.